Zaidi S Javed, Lefaiver Cheryl A, Muangmingsuk Supitcha, Cui Vivian W, Roberson David A, Penk Jamie
Pediatric Cardiology, Advocate Children's Hospital, Chicago, IL, USA.
Advocate Bromenn Medical Center, 1302 Franklin Av, Suite 1100, Normal, IL, 61761, USA.
Pediatr Cardiol. 2018 Mar;39(3):526-532. doi: 10.1007/s00246-017-1783-6. Epub 2017 Nov 28.
Quantification of right ventricular function is difficult, but important, in patients with single ventricles. Tissue motion annular displacement (TMAD) is an echocardiographic tool that measures displacement of the tricuspid valve relative to the apex. We evaluated TMAD, lateral annular displacement (LAD), and fractional area change (FAC) for correlation with outcomes. We measured TMAD, LAD, FAC, and other variables that may affect prognosis in patients with single right ventricle physiology pre- and post-Stage I palliation and correlated them with outcomes up to the Glenn procedure. Intra- and inter-observer variability for TMAD measurements were 2.7% (1.2-3.5%) and 6.1% (3.3-8.1%), respectively. Sixty-six subjects met the inclusion criteria. Pre-Stage I TMAD was 13.7% (SD 3.9%). TMAD had a linear relationship with FAC (r2 = 0.76). There was a correlation between TMAD and hospital stay (p = 0.044) and ECMO/arrest (p = 0.024). LAD correlated with ECMO/arrest (p = 0.045) and mortality/transplant (p = 0.049). FAC correlated with in-hospital mortality (p = 0.028). Post-Stage I TMAD was 11.8% (SD 3.7%). TMAD, LAD, and FAC all correlated with in-hospital mortality and mortality/transplant. In multivariate models, TMAD was independently predictive of weight for age Z score pre-Glenn. TMAD, FAC, and LAD correlate with clinically significant outcomes after the first-stage palliation. TMAD correlated with more outcomes than FAC and was the only measure that was independently predictive of any outcome. TMAD is a reproducible measure of RV function in this population. TMAD has prognostic value before and after first-stage palliation and may outperform more traditional measures.
对于单心室患者,右心室功能的量化评估虽困难但很重要。组织运动环形位移(TMAD)是一种超声心动图工具,用于测量三尖瓣相对于心尖的位移。我们评估了TMAD、侧方环形位移(LAD)和面积变化分数(FAC)与预后的相关性。我们测量了单右心室生理状态患者在I期姑息治疗前后的TMAD、LAD、FAC以及其他可能影响预后的变量,并将它们与直至格林手术的预后进行关联。TMAD测量的观察者内和观察者间变异分别为2.7%(1.2 - 3.5%)和6.1%(3.3 - 8.1%)。66名受试者符合纳入标准。I期姑息治疗前TMAD为13.7%(标准差3.9%)。TMAD与FAC呈线性关系(r2 = 0.76)。TMAD与住院时间(p = 0.044)和体外膜肺氧合/心脏骤停(p = 0.024)之间存在相关性。LAD与体外膜肺氧合/心脏骤停(p = 0.045)和死亡率/移植(p = 0.049)相关。FAC与住院死亡率(p = 0.028)相关。I期姑息治疗后TMAD为11.8%(标准差3.7%)。TMAD、LAD和FAC均与住院死亡率和死亡率/移植相关。在多变量模型中,TMAD可独立预测格林手术前年龄别体重Z评分。TMAD、FAC和LAD与I期姑息治疗后的临床显著预后相关。TMAD与预后的相关性比FAC更多,且是唯一能独立预测任何预后的指标。TMAD是该人群右心室功能的可重复测量指标。TMAD在I期姑息治疗前后均具有预后价值,且可能优于更传统的测量方法。